Key result
Prompt recognition, supportive care, and specific pharmacotherapy are essential to manage neuroleptic malignant syndrome.
Early recognition and aggressive supportive care with specific pharmacologic therapy are crucial for managing life-threatening neuroleptic malignant syndrome.
Answers are grounded in this paper and cite their sources.
Supports vigilance for neuroleptic malignant syndrome in antipsychotic users; leaves open optimal pharmacologic regimens for prospective trials.
Neuroleptic malignant syndrome is a relatively uncommon life-threatening disorder. The widespread use of the neuroleptic and psychotropic medications, however, makes it important for the primary care physician to understand the clinical presentation, differential diagnosis, and management of neuroleptic malignant syndrome. Early recognition should be possible. Rapid diagnosis followed by aggressive supportive care and specific pharmacologic therapy can be life saving.
No takes yet. Share an insight, caveat, or question.
Connelly et al. (1992) conducted a review in Neuroleptic malignant syndrome. Neuroleptic and psychotropic medications was evaluated. Neuroleptic malignant syndrome is a life-threatening disorder requiring early recognition, rapid diagnosis, aggressive supportive care, and specific pharmacologic therapy.
Synapse has enriched 9 related papers. Consider them for comparative context: